Grifols is a global biopharmaceutical company specializing in the development of plasma-derived medicines for the treatment of rare and chronic, often life-threatening diseases for which few or no alternative therapies exist. The company operates the world’s largest network of plasma donation centers and is also a leader in transfusion medicine, helping ensure the safety and availability of the blood supply. In addition, Grifols provides biological materials and advanced research solutions, as well as tools and services that enable hospitals to deliver efficient patient care. With operations in more than 110 countries and a strong commitment to research and innovation, Grifols contributes to the development of advanced therapies and the improvement of patients’ quality of life.

As the authorized distributor of Grifols products in Slovenia, Mediline supplies immunohematology instruments and blood grouping reagents.